People struggling with opioid use disorder often face a difficult path toward recovery. When they visit an emergency department, that moment can be a critical window for starting life-saving medication like buprenorphine. This new study aims to see if a higher initial dose can make that transition more effective.
Researchers are designing a trial involving 360 patients in emergency departments. They will compare a high-dose induction of 24 mg against the standard 8 mg dose. The goal is to see if the higher dose leads to better engagement with long-term treatment and helps manage cravings and withdrawal symptoms.
Because this is currently a study protocol, no results have been gathered yet. The team will follow patients for up to 30 days to track their progress. While we don't have data on safety or success rates just yet, the study aims to improve how doctors provide care in emergency settings.